Literature DB >> 20032395

Numerical abnormalities of chromosome 9 and p16CDKN2A gene deletion detected by FISH in non-small cell lung cancer.

Anna D Panani1, Katerina Maliaga, Athanasia Babanaraki, Ion Bellenis.   

Abstract

BACKGROUND: Lung cancer is one of the most common types of cancer worldwide and its pathogenesis is closely associated with various environmental exposures and gene alterations. The identification of genetic changes is a useful strategy toward understanding tumourigenesis and specific genetic associations. Since the tumor suppressor gene p16 located at 9p21 chromosomal region might have an important role in lung carcinogenesis, the aim of the present study was to investigate p16 gene alterations and numerical aberrations of chromosome 9 in non-small cell lung cancer.
MATERIALS AND METHODS: Nineteen cases of non-small cell lung cancer (11 squamous cell carcinomas, 6 adenocarcinomas and 2 large cell carcinomas) were investigated by fluorescence in situ hybridization (FISH) technique using a DNA p16 probe and alpha-satellite probe specific for chromosome 9.
RESULTS: Polysomy 9 was found in 13 cases (6/11 squamous cell carcinomas, 5/6 adenocarcinomas and 2/2 large cell carcinomas). p16 gene alterations were found in 16 cases. Among them, deletion of p16 gene was found in 15 cases (8/11 squamous cell carcinomas, 5/6 adenocarcinomas and 2/2 large cell carcinomas). In six cases with p16 gene deletion, homozygous deletion was observed.
CONCLUSION: Numerical aberrations of chromosome 9 and p16 gene deletion are common findings in all subtypes of non-small cell lung cancer. Despite suggesting the p16 gene in the 9p chromosomal region plays a role in lung carcinogenesis, the presence of other oncogenes reflected by polysomy 9 participating in the neoplastic process cannot be excluded. Data of the present study also suggest, that there might not be a fundamental relationship between genetic changes and histological subtype of non-small cell lung cancer.

Entities:  

Mesh:

Year:  2009        PMID: 20032395

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines.

Authors:  Beate Pesch; Dirk Taeger; Georg Johnen; Katarzyna Gawrych; Nadine Bonberg; Christian Schwentner; Harald Wellhäusser; Matthias Kluckert; Gabriele Leng; Michael Nasterlack; Yair Lotan; Arnulf Stenzl; Thomas Brüning
Journal:  Int Arch Occup Environ Health       Date:  2013-10-16       Impact factor: 3.015

2.  Speckle-type POZ (pox virus and zinc finger protein) protein gene deletion in ovarian cancer: Fluorescence in situ hybridization analysis of a tissue microarray.

Authors:  Xiaoyu Hu; Zhu Yang; Manman Zeng; Y I Liu; Xiaotao Yang; Yanan Li; X U Li; Qiubo Yu
Journal:  Oncol Lett       Date:  2016-05-30       Impact factor: 2.967

3.  The predictive role of p16 deletion, p53 deletion, and polysomy 9 and 17 in pancreatic ductal adenocarcinoma.

Authors:  Yanli Luo; Ling Tian; Ye Feng; Miaoying Yi; Xiafang Chen; Qian Huang
Journal:  Pathol Oncol Res       Date:  2012-07-11       Impact factor: 3.201

4.  The transcriptional consequences of somatic amplifications, deletions, and rearrangements in a human lung squamous cell carcinoma.

Authors:  Lucy F Stead; Stefano Berri; Henry M Wood; Philip Egan; Caroline Conway; Catherine Daly; Kostas Papagiannopoulos; Pamela Rabbitts
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

5.  Proteogenomic analysis of human chromosome 9-encoded genes from human samples and lung cancer tissues.

Authors:  Jung-Mo Ahn; Min-Sik Kim; Yong-In Kim; Seul-Ki Jeong; Hyoung-Joo Lee; Sun Hee Lee; Young-Ki Paik; Akhilesh Pandey; Je-Yoel Cho
Journal:  J Proteome Res       Date:  2013-12-06       Impact factor: 4.466

6.  p16 protein is upregulated in a stepwise fashion in colorectal adenoma and colorectal carcinoma.

Authors:  Mahmoud Al-Ahwal; Wafaey Gomaa; Eman Emam; Yousif Qari; Abdelbaset Buhmeida; Salman Radwi; Basim Al-Maghrabi; Mohammad Al-Qahtani; Jaudah Al-Maghrabi
Journal:  Saudi J Gastroenterol       Date:  2016-11       Impact factor: 2.485

7.  Exploring the Mechanism of Curcumin on Retinoblastoma Based on Network Pharmacology and Molecular Docking.

Authors:  Chengfu Wu; Wenli Zheng; Jifa Zhang; Xingping He
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-19       Impact factor: 2.650

Review 8.  Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy.

Authors:  Marion Grard; Camille Chatelain; Tiphaine Delaunay; Elvire Pons-Tostivint; Jaafar Bennouna; Jean-François Fonteneau
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

9.  Lung cancer in which the hypothesis of multi-step progression is confirmed by array-CGH results: A case report.

Authors:  Daniela Bettio; Anna Venci; Valentina Achille; Marco Alloisio; Armando Santoro
Journal:  Exp Ther Med       Date:  2015-11-16       Impact factor: 2.447

10.  Loss of CDKN2A at chromosome 9 has a poor clinical prognosis and promotes lung cancer progression.

Authors:  Wei Liu; Congwen Zhuang; Tengfei Huang; Shengsheng Yang; Meiqing Zhang; Baoquan Lin; Yi Jiang
Journal:  Mol Genet Genomic Med       Date:  2020-11-06       Impact factor: 2.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.